Find clinical trials for Non-Hodgkin Lymphoma in Charlotte, NC
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Non-Hodgkin Lymphoma trials near Charlotte, NC, USA:
This is a global Phase 2, open-label, single-arm, multicohort, multicenter study to evaluate efficacy and safety of JCAR017 in adult subjects with r/...
Phase 2
Charlotte, North Carolina, United States and 37 other locations
patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), or Non-Hodgkin's Lymphomas wh...
Phase 1
Rock Hill, South Carolina, United States of America and 29 other locations
017 works in treating patients with non-Hodgkin's lymphoma whose disease has come back or has not responded to treatment....
Phase 1
Charlotte, North Carolina, United States and 13 other locations
(CAR) T cells, in subjects with relapsed or refractory B-cell non-Hodgkin lymphoma.The study will consist of 2 parts: dose...
Phase 1
Charlotte, North Carolina, United States and 13 other locations
B-cell Lymphoma is an aggressive and rare cancer of a type of immune cell (a white blood cell responsible for fighting infections). The purp-...
Phase 2
Charlotte, North Carolina, United States and 74 other locations
additional open-label imaging feasibility sub-study using a tracer in adult participants with relpased/refractory B-cell non-Hodgkin...
Phase 1, Phase 2
Charlotte, North Carolina, United States and 19 other locations
This study will evaluate the safety, efficacy, and pharmacokinetics of mosunetuzumab or glofitamab in combination with CELMoDs (CC-220 or CC-99282) i...
Phase 1
Charlotte, North Carolina, United States and 26 other locations
gemcitabine, and oxaliplatin (R-GemOx).To evaluate the efficacy of magrolimab in combination with rituximab in participants with indolent lymphoma...
Phase 1, Phase 2
Charlotte, North Carolina, United States and 19 other locations
bispecific antibody, in subjects with relapsed or refractory B-cell non-Hodgkin lymphoma (B-NHL) who have received 2 or mo...
Phase 1
Charlotte, North Carolina, United States and 28 other locations
with polatuzumab vedotin in participants with diffuse large B-cell lymphoma (DLBCL), follicular lymphoma (FL), and mantle cell lymphoma...
Phase 1, Phase 2
Charlotte, North Carolina, United States and 28 other locations
Clinical trials
Research sites
Resources
Legal